This oral GLP-1 receptor agonist could potentially improve patient compliance and accessibility in treating obesity and type 2 diabetes
Our weight loss program in East Bakersfield, California uses GLP-1 medications including Ozempic, Mounjaro, Wegovy, Zepbound, and more to help patients lose weight and reach their goals under the guidance of a licensed provider
Some visits (about 6%) were due to allergic reactions
They can monitor whether weight loss or changes in eating patterns affect your depression and adjust your treatment plan if needed
Your #strategy should too
Patients with insufficient weight loss at any time point were offered semaglutide therapy with doses titrated depending on response to treatment, tolerability, availability and affordability